Understanding how the immune system controls KSHV infection
Cell Intrinsic Immune Control of KSHV
This study is looking at how the immune system fights the Kaposi’s sarcoma-associated herpesvirus (KSHV), which can cause serious health issues for people with weakened immune systems, to find ways to improve treatments for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10733449 on NIH RePORTER |
What this research studies
This research investigates the role of the immune system in controlling Kaposi’s sarcoma-associated herpesvirus (KSHV), which is linked to several serious conditions in immunocompromised individuals. The study focuses on specific immune sensors that detect KSHV infection and how they respond to it. By examining the interactions between KSHV and immune responses, the research aims to uncover mechanisms that could lead to better treatments for KSHV-related diseases. Patients may benefit from insights gained about how to enhance immune responses against this virus.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are immunocompromised or have conditions associated with KSHV, such as AIDS or certain cancers.
Not a fit: Patients who are not immunocompromised or do not have any KSHV-related conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating KSHV-related diseases in vulnerable populations.
How similar studies have performed: Other research has shown success in understanding immune responses to viral infections, suggesting that this approach could yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Karijolich, John — Vanderbilt University Medical Center
- Study coordinator: Karijolich, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.